Risk aversion and COVID‐19 vaccine hesitancy - HAL Accéder directement au contenu
Article dans une revue Health Economics Année : 2023

Risk aversion and COVID‐19 vaccine hesitancy

Résumé

We here investigate the role of risk aversion in COVID‐19 vaccine hesitancy. The theoretical effect is ambiguous, as both COVID‐19 infection and vaccination side‐effects involve probabilistic elements. In large‐scale data covering five European countries, we find that vaccine hesitancy falls with risk aversion, so that COVID‐19 infection is perceived as involving greater risk than is vaccination.
Loading...

Dates et versions

halshs-04206111, version 1 (13-09-2023)

Licence

Paternité - CC BY 4.0

Identifiants

Citer

Anthony Lepinteur, Liyousew Borga, Andrew E. Clark, Claus Vögele, Conchita D’ambrosio. Risk aversion and COVID‐19 vaccine hesitancy. Health Economics, 2023, 32 (8), pp.1659-1669. ⟨10.1002/hec.4693⟩. ⟨halshs-04206111⟩
23 Consultations
0 Téléchargements
Dernière date de mise à jour le 28/04/2024
comment ces indicateurs sont-ils produits

Altmetric

Partager

Gmail Facebook Twitter LinkedIn Plus